Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2023-02, Vol.98 (2), p.E41-E44
Hauptverfasser:	Wieczorek, Michele, Labopin, Myriam, Castagna, Luca, Brissot, Eolia, Socié, Gerard, Raiola, Anna Maria, Angelucci, Emanuele, Rodríguez, Arancha Bermúdez, Yakoub‐Agha, Ibrahim, Aljurf, Mahmoud, Crawley, Charles, Mear, Jean Baptiste, Musso, Maurizio, Fanin, Renato, Avenoso, Daniele, Turlure, Pascal, Tecchio, Cristina, Sanz, Jaime, Ciceri, Fabio, Nagler, Arnon, Mohty, Mohamad
Format:	Artikel
Sprache:	eng
Schlagworte:	Cyclophosphamide Cyclophosphamide - therapeutic use Graft vs Host Disease - etiology Graft vs Host Disease - prevention & control Hematology Hematopoietic Stem Cell Transplantation Histocompatibility antigen HLA Humans Leukemia, Myeloid, Acute - therapy Life Sciences Retrospective Studies Stem cell transplantation Tissue Donors Transplantation Transplantation Conditioning Unrelated Donors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!